• Issue

    Pharmaceutical Statistics: Volume 16, Issue 6

    393-467
    November/December 2017
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 393-395
  • First Published: 10 November 2017

MAIN PAPERS

Bayesian adaptive dose-escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy

Wai Yin Yeung,  Bruno Reigner,  Ulrich Beyer,  Cheikh Diack,  Daniel Sabanés bové,  Giuseppe Palermo,  Thomas Jaki, 
  • Pages: 396-413
  • First Published: 09 July 2017

Bayesian nonparametric statistics: A new toolkit for discovery in cancer research

Peter F. Thall,  Peter Mueller,  Yanxun Xu,  Michele Guindani, 
  • Pages: 414-423
  • First Published: 04 July 2017

Control-based imputation for sensitivity analyses in informative censoring for recurrent event data

Fei Gao,  Guanghan F. Liu,  Donglin Zeng,  Lei Xu,  Bridget Lin,  Guoqing Diao,  Gregory Golm,  Joseph F. Heyse,  Joseph G. Ibrahim, 
  • Pages: 424-432
  • First Published: 22 August 2017

Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycle

Shinjo Yada,  Chikuma Hamada, 
  • Pages: 433-444
  • First Published: 25 August 2017

Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy

Douglas F. Arbetter,  Purva Jain,  Megan K. Yee,  Nathan Michalak,  Adrian F. Hernandez,  Russell D. Hull,  Samuel Z. Goldhaber,  Robert A. Harrington,  Alex Gold,  Alexander T. Cohen,  C. Michael Gibson, 
  • Pages: 445-450
  • First Published: 24 August 2017

A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test

Qingzhao Yu,  Lin Zhu,  Han Zhu, 
  • Pages: 451-465
  • First Published: 04 October 2017

BOOK REVIEW

Be a model communicator (and sell your models to anyone) Peter L. Bonate, 2014 ISBN 978-0-692-32381-6; $19.99

Andreas Krause, 
  • Pages: 466-467
  • First Published: 09 August 2017